{"nct_id":"NCT06077760","title":"A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2023-12-06","start_date_type":"ACTUAL","primary_completion_date":"2030-06-25","primary_completion_date_type":"ESTIMATED","completion_date":"2035-12-21","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}